Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERFECT: Paliperidone ER in Schizophrenia
NCT00761579Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Apr 2008; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00761579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761579.